News & Podcast

Munich medtech startup Bugsense Diagnostics receives 1.23 million euros from the EXIST Transfer of Research funding program of the Federal Ministry for Economic Affairs and Energy (BMWE). With this funding, the 2023 m4 Award winner aims to further develop its paper-based point-of-care technology over the next two years through to clinical application for the rapid diagnosis of urinary tract infections and the detection of antimicrobial resistance.

From Munich quantum research to personalized medicine: Qtas, a startup founded in 2025 by Robin Allert, Karl Briegel, and Nick von Grafenstein, develops technology that makes extremely rare tumor cells in blood samples visible and analyzable. In the interview, CEO Robin Allert explains how personal experiences and quantum sensing formed the foundation for the company.

The 4C Accelerator is launching its twelfth round: Until August 3, 2026, medtech startups can apply for the funding program. Participants can expect a combination of workshops and individual coaching with a focus on regulatory requirements and market entry.

The medtech startup Sedivention has completed a €2.9 million seed funding round led by bmp Ventures with the IBG Fonds. With the capital, the company plans to further develop a minimally invasive outpatient therapy for obesity and generate initial clinical data for its planned market entry.

The Munich-based startup Onyx Biotech has completed a pre-seed funding round with the Life Science Valley Growth Fund, Freiraum Ventures, and several business angels. Founded in 2024, the company develops simulation-based digital twins that are designed to save up to 96 percent of laboratory experiments in the development of modern biologics.

Rnatics is developing RCS-21, a novel inhalable drug against lung inflammation and idiopathic pulmonary fibrosis. The startup was founded in 2021 as a spin-off from TUM by Stefan Engelhardt together with Thomas Frischmuth and Klaus Rabe. After promising research and ongoing clinical studies, the team aims to reach the next milestones and create new therapy options for patients. Clinical lead and pharmacist with a PhD, Christina Beck, explains the details about the founding and mission to us.

XO Life was founded in 2021 and develops a globally unique meta-platform from Munich. It is designed to support patients from diagnosis through the start of therapy to digital support during the course of treatment. Now the Munich-based digital health startup is securing new capital.

Munich-based biotech unicorn Tubulis is being acquired by US company Gilead for a multibillion-euro amount.

Munich startup Custom Surgical has completed a pre-series A funding round, is moving into new offices at the Munich Technology Center, and plans to double its team. The company combines hardware, cloud platform, and AI to digitalize and scale ophthalmological diagnostics.

Munich-based software provider Avelios Medical receives a strategic investment from SAP. Together, the partners are developing a new digital platform for hospitals, responding to the planned replacement of central IT systems in the clinical market.

Medtech startup Noxon has completed seed funding of several million euros. Goal: to certify the muscle-computer interface for rehabilitation and neurology.

Munich-based medtech startup Custom Surgical receives 3.5 million euros from Ventech, Zeiss, and other investors. With the pre-Series A round, the company is advancing the digitalization of workflows in ophthalmology and its international expansion.